Skip to main content
Panicos Shangaris

Dr Panicos Shangaris

Clinical Senior Lecturer and Consultant in Maternal and Fetal Medicine

Biography

Panicos is a Clinical Senior Lecturer and Consultant in Maternal & Fetal Medicine at King's College London and Kings College Hospital (KCH). He completed his Masters's degree in Fetal Medicine and Prenatal Genetics from UCL with distinction, and later pursued a PhD at the same institution on the subject of treating genetic blood disorders by transplanting stem cells or gene therapy to the fetus. During this time, he was supervised by Professor Anna David and Professor Paolo De Coppi.

After completing his PhD, Panicos joined KCL as an NIHR Clinical Lecturer and sub-specialised in Maternal and Fetal medicine, working at Guy's and St Thomas' Hospitals and KCH. His research work has focused on prenatal therapy for Sickle Cell Disease and the immunology of pregnancy. He is currently supervising PhD, MSc and BSc students and has received funding from various organisations including the Wellcome Trust, the Academy of Medical Sciences, NIHR, and the Fetal Medicine Foundation. He is working closely with Professors Kypros Nicolaides, John Strouboulis, and Giovanna Lombardi, demonstrating his commitment to collaborative research in the field.

    Research

    Pericles logo
    Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)

    To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.

    Project status: Ongoing

    T-cells thumbnail
    Regulatory T Cells in Pregnancy Adverse Outcomes (Rutepo)

    Tregs play a critical role in maintaining immune tolerance during pregnancy, and their dysfunction has been associated with pregnancy complications.

    Project status: Ongoing

    sickle-cell-blood-780x450
    Shangaris Group

    Our lab is dedicated to exploring and advancing prenatal therapy and pregnancy immunology. Our team conducts innovative research emphasising understanding and treating sickle cell disease (SCD) through prenatal interventions.

    fetal-image
    Vlachodimitropoulou Group

    Vlachodimitropoulou Group - our lab stands at the forefront of maternal and fetal health. With a specialized focus on fetal therapy and maternal and fetal hematology.

      Research

      Pericles logo
      Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)

      To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.

      Project status: Ongoing

      T-cells thumbnail
      Regulatory T Cells in Pregnancy Adverse Outcomes (Rutepo)

      Tregs play a critical role in maintaining immune tolerance during pregnancy, and their dysfunction has been associated with pregnancy complications.

      Project status: Ongoing

      sickle-cell-blood-780x450
      Shangaris Group

      Our lab is dedicated to exploring and advancing prenatal therapy and pregnancy immunology. Our team conducts innovative research emphasising understanding and treating sickle cell disease (SCD) through prenatal interventions.

      fetal-image
      Vlachodimitropoulou Group

      Vlachodimitropoulou Group - our lab stands at the forefront of maternal and fetal health. With a specialized focus on fetal therapy and maternal and fetal hematology.